Notably, the activation of HH signaling is a key-driver of resistance to 5-FU in LoVo cells and GLI1 and GLI2 knockdown sensitizes gastric cancer and CRC cells to 5-FU [44, 45]. This evidence concerns the gene GLI1 and colorectal carcinoma.